Fortrea Holdings Inc. (FTRE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Fortrea Holdings Inc. (FTRE) has a cash flow conversion efficiency ratio of 0.149x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($86.80 Million) by net assets ($580.80 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Fortrea Holdings Inc. defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Fortrea Holdings Inc. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Fortrea Holdings Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Fortrea Holdings Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fortrea Holdings Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jupiter Life Line Hospitals Limited
NSE:JLHL
|
-0.009x |
|
Huangshan Novel Co Ltd
SHE:002014
|
0.114x |
|
Hartalega Holdings Bhd
KLSE:5168
|
0.029x |
|
Ameresco Inc
NYSE:AMRC
|
0.016x |
|
Chongqing Baiya Sanitary Products Co
SHE:003006
|
0.059x |
|
Ulker Biskuvi Sanayi AS
IS:ULKER
|
0.050x |
|
Jiaxing ZMAX Optech Co. Ltd. A
SHG:688307
|
N/A |
|
Blue Jet Healthcare Limited
NSE:BLUEJET
|
0.152x |
Annual Cash Flow Conversion Efficiency for Fortrea Holdings Inc. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Fortrea Holdings Inc. from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see FTRE market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.36 Billion | $262.80 Million | 0.193x | +96.34% |
| 2023-12-31 | $1.71 Billion | $168.40 Million | 0.098x | +297.09% |
| 2022-12-31 | $3.34 Billion | $82.70 Million | 0.025x | -52.49% |
| 2021-12-31 | $3.26 Billion | $169.80 Million | 0.052x | -- |
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include f… Read more